Showing results (111-120 of 1,815) with videos related to

Sort By:
Pageof 182
Signal Transduction and Targeted Therapy|December 20, 2024
A phase 2 pilot study of umbilical cord blood infusion as an adjuvant consolidation therapy in elderly patients with acute myeloid leukemiaJinzeng Wang, Xiaoyang Li, Ping Liu, et al.
Signal Transduction and Targeted Therapy|December 12, 2024
Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trialLixia Yi, Haoqi Pan, Zhouyu Ning, et al.
Signal Transduction and Targeted Therapy|December 10, 2024
Alternating modified CAPOX/CAPIRI plus bevacizumab in untreated unresectable metastatic colorectal cancer: a phase 2 trialSheng Li, Xiaoyou Li, Hanfeng Xu, et al.
Signal Transduction and Targeted Therapy|December 9, 2024
Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trialYaoping Shi, Dan Cui, Lei Xia, et al.
Signal Transduction and Targeted Therapy|November 20, 2024
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variantsHong Lei, Weiqi Hong, Jingyun Yang, et al.
Signal Transduction and Targeted Therapy|November 12, 2024
Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trialXuhua Duan, Hao Li, Donglin Kuang, et al.
Signal Transduction and Targeted Therapy|November 5, 2024
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2Ran An, Hao Yang, Cong Tang, et al.
Signal Transduction and Targeted Therapy|November 17, 2024
2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosusHuiqi Yin, Liming Li, Xiwei Feng, et al.
Signal Transduction and Targeted Therapy|October 17, 2024
Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapyLiuqing Yang, Ye Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy|October 22, 2024
Ruxolitinib plus steroids for acute graft versus host disease: a multicenter, randomized, phase 3 trialLiping Dou, Yanli Zhao, Jingjing Yang, et al.
Pageof 182